Human-Induced Pluripotent Stem Cells in Plastic and Reconstructive Surgery

Int J Mol Sci. 2024 Feb 3;25(3):1863. doi: 10.3390/ijms25031863.

Abstract

A hallmark of plastic and reconstructive surgery is restoring form and function. Historically, tissue procured from healthy portions of a patient's body has been used to fill defects, but this is limited by tissue availability. Human-induced pluripotent stem cells (hiPSCs) are stem cells derived from the de-differentiation of mature somatic cells. hiPSCs are of particular interest in plastic surgery as they have the capacity to be re-differentiated into more mature cells, and cultured to grow tissues. This review aims to evaluate the applications of hiPSCs in the plastic surgery context, with a focus on recent advances and limitations. The use of hiPSCs and non-human iPSCs has been researched in the context of skin, nerve, vasculature, skeletal muscle, cartilage, and bone regeneration. hiPSCs offer a future for regenerated autologous skin grafts, flaps comprised of various tissue types, and whole functional units such as the face and limbs. Also, they can be used to model diseases affecting tissues of interest in plastic surgery, such as skin cancers, epidermolysis bullosa, and scleroderma. Tumorigenicity, immunogenicity and pragmatism still pose significant limitations. Further research is required to identify appropriate somatic origin and induction techniques to harness the epigenetic memory of hiPSCs or identify methods to manipulate epigenetic memory.

Keywords: induced pluripotent stem cells (iPSC); plastic surgery; reconstructive surgery; regenerative medicine; tissue engineering.

Publication types

  • Review

MeSH terms

  • Cell Differentiation
  • Humans
  • Induced Pluripotent Stem Cells*
  • Plastic Surgery Procedures*
  • Skin
  • Surgery, Plastic*

Grants and funding

This research received no external funding.